Yoshiyuki Takei

Yoshiyuki Takei

Auto-generated profile, based on publicly available information

Yoshiyuki Takei

Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Mie, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2015 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CKChika Kasai
Chika Kasai
KSKazushi Sugimoto
Kazushi Sugimoto
IMIsao Moritani
Isao Moritani
JTJunichiro Tanaka
Junichiro Tanaka
YOYumi Oya
Yumi Oya
KTKojiro Takase
Kojiro Takase
Obesity has become one of the most serious social problems in developed countries, including Japan. The relationship between the gut microbiota and obesity has recently attracted the attention of many researchers. Although the gut microbiota was long thought to contribute to obesity, the exact association remains largely unknown. We examined the human gut microbiota composition in a Japanese population in order to determine its relationship to obesity. Stool samples from 23 non-obese subjects (body mass index [BMI] <20 kg/m2) and 33 obese subjects (BMI ≥25 kg/m2) were collected and DNA was extracted prior to colonoscopy. After terminal restriction fragment length polymorphism (T-RFLP) analysis, samples from 10 subjects (4 non-obese and 6 obese) were selected and subjected to next-generation sequencing for species-level analysis. T-RFLP analysis showed significantly reduced numbers of Bacteroidetes and a higher Firmicutes to Bacteroidetes ratio in obese subjects compared with non-obese subjects. Bacterial diversity was significantly greater in obese subjects compared with non-obese subjects. Next-generation sequencing revealed that obese and non-obese subjects had different gut microbiota compositions and that certain bacterial species were significantly associated with each group (obese: Blautia hydrogenotorophica, Coprococcus catus, Eubacterium ventriosum, Ruminococcus bromii, Ruminococcus obeum; non-obese: Bacteroides faecichinchillae, Bacteroides thetaiotaomicron, Blautia wexlerae, Clostridium bolteae, Flavonifractor plautii). Gut microbial properties differ between obese and non-obese subjects in Japan, suggesting that gut microbiota composition is related to obesity.

17 September 2009 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
TMTomokazu Mizui
Tomokazu Mizui
SYShunhei Yamashina
Shunhei Yamashina
ITIsei Tanida
Isei Tanida
YTYoshiyuki Takei
Yoshiyuki Takei
TUTakashi Ueno
Takashi Ueno
SWSumio Watanabe
Sumio Watanabe

1 June 2001 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
NENobuyuki Enomoto
Nobuyuki Enomoto
KIKenichi Ikejima
Kenichi Ikejima
SYShunhei Yamashina
Shunhei Yamashina
MHMiyoko Hirose
Miyoko Hirose
HSHidetake Shimizu
Hidetake Shimizu
RTRonald G. Thurman
Ronald G. Thurman

1 September 2010 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
SHShiraki
Shiraki
JTJunichiro Tanaka
Junichiro Tanaka
KSKazushi Sugimoto
Kazushi Sugimoto
KSKatsuya Shiraki
Katsuya Shiraki
MTMasahiko Tameda
Masahiko Tameda
YTYoshiyuki Takei
Yoshiyuki Takei
Toll-like receptor 9 (TLR9) is a pattern-recognition receptor that is involved in immune signaling and plays a crucial role in cell survival through recognition of various bacterial and viral components including unmethylated CpG-DNA. TLR9 expression and function in cancer cells are not well understood. We investigated the expression of TLR9, and the function of TLR9 signaling, in hepatocellular carcinoma (HCC) cells following stimulation with CpG-oligodeoxynucleotides (ODNs). Positive immunohistochemical staining for TLR9 was observed in 85.7% of HCC tissues. Western blot analysis revealed that TLR9 was expressed both on the cell membrane and in the cytoplasm of HCC cell lines. Full-length TLR9 was predominantly expressed on the membrane rather than in the cytoplasm, whereas multiple cleaved forms of TLR9 were predominantly expressed in the cytoplasm rather than on the membrane. Cell surface stimulation of TLR9 promoted cell proliferation, and, furthermore, the TLR9 agonists, CpG-ODNs, reduced the cytotoxicity of the anti-cancer drug adriamycin (ADM) via up-regulation of apoptosis inhibitors such as survivin, Bcl-xL, XIAP and cFLIP, in HCC cell lines. Although cell surface stimulation of TLR9 did not activate either the NF-κB signaling pathway or the type-I IFN secretion pathway, gene chip microarray analysis indicated that TLR9 agonists closely regulated multiple oncology-related genes and transcription factors involved in tumorigenesis and cancer progression. In conclusion, our results indicate that functional cell surface expression of TLR9 in human HCC may play an important role in tumorigenesis and cancer progression.

2 March 2015 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
MIMotoh Iwasa
Motoh Iwasa
YTYoshiyuki Takei
Yoshiyuki Takei

1 May 2013 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
MFMasashi Fujimori
Masashi Fujimori
HTHaruyuki Takaki
Haruyuki Takaki
ANAtsuhiro Nakatsuka
Atsuhiro Nakatsuka
JUJunji Uraki
Junji Uraki
TYTakashi Yamanaka
Takashi Yamanaka
KYKoichiro Yamakado
Koichiro Yamakado